We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
82 hedge funds and large institutions have $235M invested in State Street SPDR S&P Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
171% more call options, than puts
Call options by funds: $2.15M | Put options by funds: $795K
100% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 8
63% more capital invested
Capital invested by funds: $144M → $235M (+$91.3M)
35% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 20
13.63% more ownership
Funds ownership: 62.63% → 76.26% (+14%)
6% more funds holding
Funds holding: 77 → 82 (+5)
Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
20
Closed
8
Calls
$2.15M
Puts
$795K
Net Calls
+$1.36M
Net Calls Change
-$849K
Top Buyers
| 1 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$40.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$25.4M |
| 3 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
+$16.5M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$11M |
| 5 |
Morgan Stanley
New York
|
+$8.16M |
Top Sellers
| 1 |
Citigroup
New York
|
-$5.91M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$5.01M |
| 3 |
LPL Financial
San Diego,
California
|
-$3.42M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.67M |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$1.32M |
